Literature DB >> 33093118

Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort.

Raphael Lhote1,2, Isabella Annesi-Maesano1, Hilario Nunes3, David Launay4, Raphael Borie5, Karim Sacré6, Nicolas Schleinitz7, Mohamed Hamidou8, Matthieu Mahevas9, Hervé Devilliers10, Philippe Bonniaud11, François Lhote12, Julien Haroche2, Pierre Rufat13, Zahir Amoura2, Dominique Valeyre3, Fleur Cohen Aubart14.   

Abstract

Sarcoidosis is a rare disease of unknown cause with wide heterogeneity in clinical features and outcomes. We aimed to explore sarcoidosis phenotypes and their clinical relevance with particular attention to extrapulmonary subgroups.The Epidemiology of Sarcoidosis (EpiSarc) study is a French retrospective multicentre study. Sarcoidosis patients were identified through national hospitalisation records using appropriate codes from 11 hospital centres between 2013 and 2016 according to a standardised protocol. Medical charts were reviewed. The phenotypes of sarcoidosis were defined using a hierarchical cluster analysis.A total of 1237 patients were included (562 men and 675 women). The mean age at sarcoidosis diagnosis was 43.5±13 years. Hierarchical cluster analysis identified five distinct phenotypes according to organ involvement and disease type and symptoms: 1) erythema nodosum, joint involvement and hilar lymph nodes (n=180); 2) eye, neurological, digestive and kidney involvement (n=137); 3) pulmonary involvement with fibrosis and heart involvement (n=630); 4) lupus pernio and a high percentage of severe involvement (n=41); and 5) hepatosplenic, peripheral lymph node and bone involvement (n=249). Phenotype 1 was associated with being European/Caucasian and female and with non-manual work, phenotype 2 with being European/Caucasian, and phenotypes 3 and 5 with being non-European/Caucasian. The labour worker proportion was significantly lower in phenotype 5 than in the other phenotypes.This multicentre study confirms the existence of distinct phenotypes of sarcoidosis, with a non-random distribution of organ involvement. These phenotypes differ according to sex, geographical origin and socioprofessional category.
Copyright ©ERS 2021.

Entities:  

Year:  2021        PMID: 33093118     DOI: 10.1183/13993003.01160-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  Clinical phenotyping in sarcoidosis using cluster analysis.

Authors:  Nancy W Lin; Jaron Arbet; Margaret M Mroz; Shu-Yi Liao; Clara I Restrepo; Annyce S Mayer; Li Li; Briana Q Barkes; Sarah Schrock; Nabeel Hamzeh; Tasha E Fingerlin; Nichole E Carlson; Lisa A Maier
Journal:  Respir Res       Date:  2022-04-09

Review 2.  How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.

Authors:  Dominique Valeyre; Florence Jeny; Cécile Rotenberg; Diane Bouvry; Yurdagül Uzunhan; Pascal Sève; Hilario Nunes; Jean-François Bernaudin
Journal:  Adv Ther       Date:  2021-07-22       Impact factor: 3.845

3.  Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis.

Authors:  Steven Ronsmans; Jolien De Ridder; Eline Vandebroek; Stephan Keirsbilck; Benoit Nemery; Peter H M Hoet; Steven Vanderschueren; Wim A Wuyts; Jonas Yserbyt
Journal:  Respir Res       Date:  2021-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.